Endocan Corp
Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food brands. It also provides over the counter products for hair and skin include Hempery miracle oil, a skin care solution; Hemp milk body wash, a creamy soap; Hemp lotion bars for moisturizing hands and bod… Read more
Market Cap & Net Worth: Endocan Corp (ENDO)
Endocan Corp (PINK:ENDO) has a market capitalization of $58.79K ($58.79K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46622 globally and #14507 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Endocan Corp's stock price $0.00 by its total outstanding shares 587936147 (587.94 Million).
Endocan Corp Market Cap History: 2015 to 2025
Endocan Corp's market capitalization history from 2015 to 2025. Data shows change from $3.41 Million to $58.79K (-36.98% CAGR).
Endocan Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Endocan Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ENDO by Market Capitalization
Companies near Endocan Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Endocan Corp by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #71 globally with a market cap of $210.18 Billion USD.
- L'Air Liquide S.A (PINK:AIQUF): Ranked #182 globally with a market cap of $107.70 Billion USD.
- Air Liquide SA (PA:AI): Ranked #200 globally with a market cap of $99.38 Billion USD ( €96.82 Billion EUR).
- Ecolab Inc (NYSE:ECL): Ranked #266 globally with a market cap of $77.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #71 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $494.05 |
| #182 | L'Air Liquide S.A | PINK:AIQUF | $107.70 Billion | $187.03 |
| #200 | Air Liquide SA | PA:AI | $99.38 Billion | €172.22 |
| #266 | Ecolab Inc | NYSE:ECL | $77.81 Billion | $272.59 |
Endocan Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Endocan Corp's market cap moved from $3.41 Million to $ 58.79K, with a yearly change of -36.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $58.79K | 0.00% |
| 2024 | $58.79K | -50.00% |
| 2022 | $117.59K | -98.13% |
| 2021 | $6.29 Million | -71.84% |
| 2020 | $22.34 Million | +1051.52% |
| 2019 | $1.94 Million | -68.27% |
| 2018 | $6.11 Million | -57.55% |
| 2017 | $14.40 Million | -2.00% |
| 2016 | $14.70 Million | +331.03% |
| 2015 | $3.41 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Endocan Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $58.79K USD |
| MoneyControl | $58.79K USD |
| MarketWatch | $58.79K USD |
| marketcap.company | $58.79K USD |
| Reuters | $58.79K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.